(Q53307810)
Statements
Additional value of CSF amyloid-beta 40 levels in the differentiation between FTLD and control subjects. (English)
Yolande A L Pijnenburg
Robert Veerhuis
Maartje I Kester
Harry Twaalfhoven
Nicolaas A Verwey
Hans Berkhof
Philip Scheltens And
1 January 2010
20
2
445-452